bibliographicCitation |
Gerspacher M, von Sprecher A, Mah R, Anderson GP, Bertrand C, Subramanian N, Hauser K, Ball HA. N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist. Bioorganic & Medicinal Chemistry Letters. 2000 Jul;10(13):1467–70. doi: 10.1016/s0960-894x(00)00260-2. |